Pyrazolam 0.5 ,1 mg, pellet Buy Pyrazolam Pellets




Pyrazolam 0.5 ,1 mg, pellet Buy Pyrazolam Pellets

Pyrazolam 0.5 ,1 mg is a benzodiazepine derivative originally developed by a team led by Leo Sternbach at Hoffman-La Roche in the 1970s, and subsequently “rediscovered” and sold as a designer drug starting in 2012.

Pyrazolam has structural similarities to alprazolam and bromazepam. Unlike other benzodiazepines, pyrazolam does not appear to undergo metabolism, instead being excreted unchanged in the urine

Phenazepam and etizolam

Phenazepam and etizolam were the first uncontrolled benzodiazepines available for sale in the UK. Pyrazolam, flubromazepam and diclazepam are not used medicinally anywhere in the world; they are produced exclusively for the uncontrolled, recreational market. It is important to know whether potentially abused drugs like these can be detected in routine toxicological screening tests. The purpose of this study was to evaluate whether the Immunalysis Benzodiazepines ELISA kit could detect phenazepam, etizolam, pyrazolam, flubromazepam, diclazepam and its metabolite delorazepam. Their cross-reactivity was assessed by comparing the absorbance of the drug with that of oxazepam, the reference standard. This study found that these uncontrolled benzodiazepines cross-react suffi- ciently to produce a positive result with the Immunalysis Benzodiazepine ELISA kit. Cross-reactivity ranged from 79 to 107% for phenazepam, etizolam, pyrazolam, flubromazepam, diclazepam and delorazepam fortified into blood.



Additional information

Select ( mg )



There are no reviews yet.

Be the first to review “Pyrazolam 0.5 ,1 mg, pellet Buy Pyrazolam Pellets”

Your email address will not be published. Required fields are marked *